Commonwealth Equity Services LLC reduced its stake in GE HealthCare Technologies Inc. by 34.4% in the third quarter, selling 91,088 shares and leaving it with 173,486 shares valued at $13.029 million. Other notable shifts include Mirae Asset Global Investments Co. Ltd., which increased its position by 4.2% to 159,882 shares (valued at $11.842 million), and Wedge Capital Management L L P NC establishing a new position worth $26.859 million. Lineweaver Wealth Advisors LLC opened a $592,000 stake, Valicenti Advisory Services Inc. grew its holdings by 22.6% to 68,107 shares ($5.115 million), and National Bank of Canada FI more than doubled its position by 133.3% to 899,693 shares ($66.640 million). Institutional and hedge funds now own 82.06% of GEHC stock.

In its latest quarterly report, GE HealthCare Technologies posted earnings per share of $1.07, surpassing consensus estimates by $0.02, on revenue of $5.14 billion, 5.8% higher year-over-year. Return on equity reached 22.52%, while net margin stood at 10.94%. For fiscal year 2025, the company set an EPS guidance range of 4.510 to 4.630, compared with analysts’ consensus forecast of 4.68 EPS.

GE HealthCare declared a quarterly dividend of $0.035 per share, payable on February 13 to shareholders of record as of January 9. This equates to an annualized payout of $0.14 per share and a yield of approximately 0.2%, with a payout ratio of 2.89%. The move underscores the company’s commitment to returning capital while maintaining a conservative distribution relative to earnings.

A balanced mix of 14 analysts covers GEHC, with seven rating the stock as Buy and seven as Hold, resulting in a consensus Moderate Buy. The average price target across these firms stands at $89.50. Recent reaffirmations include buy ratings from Goldman Sachs, BTIG Research and Evercore ISI, while Weiss Ratings maintains a Hold view. This split reflects confidence in the company’s earnings growth potential alongside considerations of competitive dynamics in the medical imaging market.